vimarsana.com

Latest Breaking News On - Axoguard nerve protector - Page 6 : vimarsana.com

Portside Wealth Group LLC Invests $1 12 Million in AxoGen, Inc (NASDAQ:AXGN)

Portside Wealth Group LLC Invests $1 12 Million in AxoGen, Inc (NASDAQ:AXGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

AxoGen, Inc (NASDAQ:AXGN) CFO Sells $93,750 00 in Stock

AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) CFO Peter J. Mariani sold 12,500 shares of the stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $7.50, for a total transaction of $93,750.00. Following the sale, the chief financial officer now owns 63,603 shares in the company, valued […]

AxoGen, Inc (NASDAQ:AXGN) Shares Bought by ArrowMark Colorado Holdings LLC

ArrowMark Colorado Holdings LLC grew its position in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 7.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 3,921,033 shares of the medical equipment provider’s stock after acquiring an additional 263,422 shares during the period. ArrowMark Colorado Holdings LLC owned about 0.09% of AxoGen worth $35,799,000 […]

Contrasting AxoGen (NASDAQ:AXGN) & GigCapital5 (NYSE:GIA)

AxoGen (NASDAQ:AXGN – Get Free Report) and GigCapital5 (NYSE:GIA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of current ratings […]

Analysts Set AxoGen, Inc (NASDAQ:AXGN) Price Target at $15 00

Shares of AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) have earned a consensus recommendation of “Buy” from the four research firms that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a buy rating. The average 12-month target price among analysts that have issued ratings on the stock in […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.